Amicus Therapeutics Inc.

NASDAQ: FOLD · Real-Time Price · USD
7.40
0.28 (3.93%)
At close: Aug 15, 2025, 3:59 PM
7.33
-0.95%
After-hours: Aug 15, 2025, 05:04 PM EDT

Amicus Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
213.75M 246.99M 148.81M 245.2M
Short-Term Investments
36.19M 39.21M 144.78M 237.3M
Long-Term Investments
n/a n/a 4.3M -4.93M
Other Long-Term Assets
13.64M 18.55M 10M 24.43M
Receivables
101.1M 87.63M 66.2M 52.67M
Inventory
118.78M 59.7M 23.82M 26.82M
Other Current Assets
34.91M 49.53M 40.21M 34.85M
Total Current Assets
504.74M 483.06M 423.82M 596.83M
Property-Plant & Equipment
51.66M 57.98M 60.31M 63.08M
Goodwill & Intangibles
215M 218.29M 220.8M 220.8M
Total Long-Term Assets
280.3M 294.82M 300.35M 308.31M
Total Assets
785.03M 777.88M 724.17M 905.14M
Account Payables
12.95M 15.12M 15.41M 21.51M
Deferred Revenue
n/a n/a 4.94M n/a
Short-Term Debt
n/a n/a 8.55M 7.41M
Other Current Liabilities
109.19M 93.51M 74.86M 79.23M
Total Current Liabilities
148.7M 167.69M 139.02M 145.97M
Long-Term Debt
390.11M 387.86M 443.57M 432.72M
Other Long-Term Liabilities
52.17M 13.28M -37.98M -29.22M
Total Long-Term Liabilities
442.29M 450.02M 462.1M 451.8M
Total Liabilities
590.99M 617.71M 601.12M 597.77M
Total Debt
443.64M 445.06M 452.12M 440.13M
Common Stock
2.94M 2.92M 2.81M 2.81M
Retained Earnings
-2.74B -2.68B -2.53B -2.3B
Comprehensive Income
n/a 5.24M -12.11M 4.98M
Shareholders Equity
194.04M 160.17M 123.05M 307.37M
Total Investments
36.19M 39.21M 144.78M 237.3M